Santosh J. Vetticaden

2017 - DepoMed

In 2017, Santosh J. Vetticaden earned a total compensation of $686.8K as Senior Vice President Chief Medical Officer at DepoMed.

Compensation breakdown

Option Awards$265,780
Salary$98,960
Stock Awards$269,825
Other$52,194
Total$686,759

Vetticaden received $269.8K in stock awards, accounting for 39% of the total pay in 2017.

Vetticaden also received $265.8K in option awards, $99K in salary and $52.2K in other compensation.

Rankings

In 2017, Santosh J. Vetticaden's compensation ranked 10,698th out of 14,666 executives tracked by ExecPay. In other words, Vetticaden earned more than 27.1% of executives.

ClassificationRankingPercentile
All
10,698
out of 14,666
27th
Division
Manufacturing
4,169
out of 5,768
28th
Major group
Chemicals And Allied Products
1,486
out of 2,074
28th
Industry group
Drugs
1,214
out of 1,730
30th
Industry
Pharmaceutical Preparations
942
out of 1,329
29th
Source: SEC filing on March 27, 2018.

Vetticaden's colleagues

We found five more compensation records of executives who worked with Santosh J. Vetticaden at DepoMed in 2017.

2017

Arthur Higgins

DepoMed

Chief Executive Officer

2017

James Schoeneck

DepoMed

Chief Executive Officer

2017

Matthew Gosling

DepoMed

General Counsel

2017

August Moretti

DepoMed

Chief Financial Officer

2017

Srinivas Rao

DepoMed

Chief Medical Officer

News

You may also like